Spinal Muscular Atrophy (SMA) Treatment Market Overview
The Spinal Muscular Atrophy (SMA) Treatment Market is witnessing transformative growth fueled by breakthrough gene therapies and antisense oligonucleotide drugs. SMA is a rare genetic disorder characterized by progressive muscle weakness due to SMN1 gene mutations. The market has evolved dramatically since the approval of disease-modifying therapies that target the underlying genetic cause. Key...
0 Comments 0 Shares 80 Views 0 Reviews